Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
enoxaparin (lovenox) (1 trial)
Thromboembolism (Phase 3)
Venous Thromboembolism (Phase 3)
Trials (1 total)
Trial APIs (1 total)